Patel Mahesh V. — SEC Form 4 filings
SEC reporting owner CIK 1579872. 9 Form 4 filings on record with FilingPulse; latest filed 2026-06-30.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-03-12 to 2026-06-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 50,000 shares, $101,250 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: purchase of 25,000 shares @ $2.03 ($50,750) in Lipocine Inc., filed 2026-04-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Lipocine Inc. (LPCN) | Chief Executive Officer, Director | 9 | 2 legs · 50,000 sh · $101,250 | — | 7 |
Form 4 filings — Patel Mahesh V.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-30 | 4 | Lipocine Inc. (LPCN) | Grant/award (A): 52,781 (derivative) @ $2.49 | EDGAR |
| 2026-04-06 | 4 | Lipocine Inc. (LPCN) | Purchase (P): 25,000 @ $2.03 | EDGAR |
| 2026-04-02 | 4 | Lipocine Inc. (LPCN) | Purchase (P): 25,000 @ $2.02 | EDGAR |
| 2026-01-05 | 4 | Lipocine Inc. (LPCN) | Grant/award (A): 25,000 (derivative) @ $8 | EDGAR |
| 2025-12-19 | 4 | Lipocine Inc. (LPCN) | Grant/award (A): 8,629 (derivative) @ $4.20 | EDGAR |
| 2025-01-02 | 4/A | Lipocine Inc. (LPCN) | Grant/award (A): 10,320 (derivative) @ $4.80 | EDGAR |
| 2025-01-02 | 4 | Lipocine Inc. (LPCN) | Grant/award (A): 16,371 (derivative) @ $4.86 | EDGAR |
| 2024-12-30 | 4 | Lipocine Inc. (LPCN) | Grant/award (A): 26,691 (derivative) @ $4.80 | EDGAR |
| 2024-03-12 | 4 | Lipocine Inc. (LPCN) | Grant/award (A): 4,893 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1579872 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →